LK

Leen Kawas

Managing General Partner of Propel Bio Partners LLC

Los Angeles, California

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Managing General Partner

    2021

    Propel Bio Partners (www.propelbio.com) is a global venture fund that is focused on life science investments. Propel Bio provides an entire ecosystem of experts to support entrepreneurs achieve their vision.

  • Member

    2022

  • Member Board of Directors

    2022

    Biotechnology company pioneering epigenetic medicine for complex diseases. Inherent epigenetic platform detects dysregulation across multiple genes and related pathways to pioneer a new category of diagnostics and therapeutics that leverage the biology's inherent mechanism for gene regulation, to radically transform how we diagnose and treat complex diseases.

  • Member Board Of Directors

    2022

    Persephone is pioneering the use of synthetic biology for microbial products that impact patient and infant health. We are building an end-to-end platform to industrialize the development of engineered cells that restore health to damaged human ecosystems.

  • Board Observer- Investor

    2023

    Our mission is to modernize procedures for ENT surgeons through thoughtfully designed solutions, streamlined workflows, and transformative patient experiences.

  • Board Observer

    2023

2022

  • Advisor-Seattle

    2022

    Nucleate is a student-led nonprofit organization dedicated to empowering the next generation of biotech leaders. We streamline company formation so that founders can focus on translating cutting-edge science.

2022

  • Member

    2022

2011 - 2021

  • CEO & President

    2014 - 2021

  • Vice President of Research

    2011 - 2014